nafamostat has been researched along with Arterial Obstructive Diseases in 3 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moroi, K | 1 |
| Shiomi, Y | 1 |
| Kumano, H | 1 |
| Ishimura, N | 1 |
| Nishiwada, M | 1 |
| Kizaki, Y | 1 |
| Ueki, Y | 1 |
| Yoshida, K | 1 |
| Yano, M | 1 |
| Matsumoto, K | 1 |
| Miyake, S | 1 |
| Tominaga, Y | 1 |
| Eguchi, K | 1 |
| Yano, K | 1 |
| Kistler, EB | 1 |
| Lefer, AM | 1 |
| Hugli, TE | 1 |
| Schmid-Schönbein, GW | 1 |
3 other studies available for nafamostat and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Anesthesia for a patient with heparin-induced thrombocytopenia: a case report].
Topics: Aged; Anastomosis, Surgical; Anesthesia, Epidural; Anesthesia, Inhalation; Anticoagulants; Arterial | 1997 |
Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Benzamidines; Blood Component Removal; Bradykinin | 1999 |
Plasma activation during splanchnic arterial occlusion shock.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Benzamidines; Biological Factors; Cats; Celiac | 2000 |